CoChat

Comprehensive Molecular and Pathologic Evaluation of Transitional Mesothelioma Assisted by Deep Learning Approach: A Multi-Institutional Study of the International Mesothelioma Panel from the MESOPATH Reference Center

Open access
Galateau Salle, Francoise, Le Stang, Nolwenn, Tirode, Franck, Courtiol, Pierre, Nicholson, Andrew G., Tsao, Ming-Sound, Tazelaar, Henry D., Churg, Andrew, Dacic, Sanja, Roggli, Victor, Pissaloux, Daniel, Maussion, Charles, Moarii, Matahi, Beasley, Mary Beth, Begueret, Hugues, Chapel, David B., Copin, Marie Christine, Gibbs, Allen R., Klebe, Sonja, Lantuejoul, Sylvie, Nabeshima, Kazuki, Vignaud, Jean-Michel, Attanoos, Richard, Brcic, Luka, Capron, Frederique, Chirieac, Lucian R., Damiola, Francesca, Sequeiros, Ruth, Cazes, Aurélie, Damotte, Diane, Foulet, Armelle, Giusiano-Courcambeck, Sophie, Hiroshima, Kenzo, Hofman, Veronique, Husain, Aliya N., Kerr, Keith, Marchevsky, Alberto, Paindavoine, Severine, Picquenot, Jean Michel, Rouquette, Isabelle, Sagan, Christine, Sauter, Jennifer, Thivolet, Francoise, Brevet, Marie, Rouvier, Philippe, Travis, William D., Planchard, Gaetane, Weynand, Birgit, Clozel, Thomas, Wainrib, Gilles, Fernandez-Cuesta, Lynnette, Pairon, Jean-Claude, Rusch, Valerie, Girard, Nicolas · 2020 · Journal of Thoracic Oncology
Cited by 65

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Abstract

Introduction: Histologic subtypes of malignant pleural mesothelioma are a major prognostic indicator and decision denominator for all therapeutic strategies. In an ambiguous case, a rare transitional mesothelioma (TM) pattern may be diagnosed by pathologists either as epithelioid mesothelioma (EM), biphasic mesothelioma (BM), or sarcomatoid mesothelioma (SM). This study aimed to better characterize the TM subtype from a histological, immunohistochemical, and molecular standpoint. Deep learning of pathologic slides was applied to this cohort. Methods: A random selection of 49 representative digitalized sections from surgical biopsies of TM was reviewed by 16 panelists. We evaluated BAP1 expression and CDKN2A (p16) homozygous deletion. We conducted a comprehensive, integrated, transcriptomic analysis. An unsupervised deep learning algorithm was trained to classify tumors. Results: The 16 panelists recorded 784 diagnoses on the 49 cases. Even though a Kappa value of 0.42 is moderate, the presence of a TM component was diagnosed in 51%. In 49% of the histological evaluation, the reviewers classified the lesion as EM in 53%, SM in 33%, or BM in 14%. Median survival was 6.7 months. Loss of BAP1 observed in 44% was less frequent in TM than in EM and BM. p16 homozygous deletion was higher in TM (73%), followed by BM (63%) and SM (46%). RNA sequencing unsupervised clustering analysis revealed that TM grouped together and were closer to SM than to EM. Deep learning analysis achieved 94% accuracy for TM identification. Conclusion: These results revealed that the TM pattern should be classified as non-EM or at minimum as a subgroup of the SM type.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.jtho.2020.01.025

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 4 references

Cited by

See all 65

Metadata

Authors
Galateau Salle, F., Le Stang, N., Tirode, F., Courtiol, P., Nicholson, A. G., Tsao, M.-S., Tazelaar, H. D., Churg, A., Dacic, S., Roggli, V., Pissaloux, D., Maussion, C., Moarii, M., Beasley, M. B., Begueret, H., Chapel, D. B., Copin, M. C., Gibbs, A. R., Klebe, S., Lantuejoul, S., Nabeshima, K., Vignaud, J.-M., Attanoos, R., Brcic, L., Capron, F., Chirieac, L. R., Damiola, F., Sequeiros, R., Cazes, A., Damotte, D., Foulet, A., Giusiano-Courcambeck, S., Hiroshima, K., Hofman, V., Husain, A. N., Kerr, K., Marchevsky, A., Paindavoine, S., Picquenot, J. M., Rouquette, I., Sagan, C., Sauter, J., Thivolet, F., Brevet, M., Rouvier, P., Travis, W. D., Planchard, G., Weynand, B., Clozel, T., Wainrib, G., Fernandez-Cuesta, L., Pairon, J.-C., Rusch, V., & Girard, N.
Venue
Journal of Thoracic Oncology
Publisher
Elsevier BV
Published
2020-06
Volume
15
Issue
6
Pages
1037-1053
ISSN
1556-0864 (ISSN-L)
OpenAlex
W3012115385
Cited by
65
References
4
FWCI
5.42
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Comprehensive Molecular and Pathologic Evaluation of Transitional Mesothelioma Assisted by Deep Learning Approach: A Multi-Institutional Study of the International Mesothelioma Panel from the MESOPATH Reference Center. https://app.cochat.ai/papers/10.1016/j.jtho.2020.01.025
The paper
Galateau Salle, F., Le Stang, N., Tirode, F., Courtiol, P., Nicholson, A. G., Tsao, M.-S., Tazelaar, H. D., Churg, A., Dacic, S., Roggli, V., Pissaloux, D., Maussion, C., Moarii, M., Beasley, M. B., Begueret, H., Chapel, D. B., Copin, M. C., Gibbs, A. R., Klebe, S., . . . Girard, N. (2020). Comprehensive Molecular and Pathologic Evaluation of Transitional Mesothelioma Assisted by Deep Learning Approach: A Multi-Institutional Study of the International Mesothelioma Panel from the MESOPATH Reference Center. Journal of Thoracic Oncology. https://doi.org/10.1016/j.jtho.2020.01.025

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.